{'text': 'Global Clostridium difficile infections market to hit $1.5b by 2024', 'publisher': {'href': 'https://www.europeanpharmaceuticalreview.com', 'title': 'European Pharmaceutical Review'}, 'created_at': 'Fri, 23 Oct 2015 07:00:00 GMT', 'description': 'Global Clostridium difficile infections market to hit $1.5b by 2024  European Pharmaceutical Review', 'url': 'https://news.google.com/rss/articles/CBMiwAFBVV95cUxQbDNkLXpMUWFEdWpZTmY3WHlNcEI3aW80TTlKVzRNcG9PR0ZELVRKdEY4ZEZtTUpfLXNhb1Z4Z3FsWjUwWVlrM2tLdHdkWFlhVDI4SGtzWFNmTFpIYzZmWUhocmtfR2RHOUttc1cyNTB6RzBVbXFKdFJiQVdZdlJnRnc2bW9YTzAybWNSWlVNY29LY2ZGTXNlcnIzcnVXcW1SWW5mNC1oZ2ZaQ0Qxbkg1WGtsMm15V2gwMmVWOWxWS0c?oc=5&hl=en-US&gl=US&ceid=US:en'}
